Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 25;16(1):237.
doi: 10.1186/s12872-016-0397-x.

Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study

Affiliations

Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study

Sophie J Bernelot Moens et al. BMC Cardiovasc Disord. .

Abstract

Background: Patients with peripheral artery disease (PAD) are at increased risk of secondary events, which is exaggerated in the presence of type 2 diabetes mellitus. Diabetes is associated with a systemic pro-inflammatory state. We therefore investigated the cumulative impact of PAD and type 2 diabetes on carotid arterial wall inflammation. As recent data suggest a detrimental role of exogenous insulin on cardiovascular disease, we also included a group of insulin users.

Results: 18F-fluorodeoxyglucose positron emission tomography with computed tomography (18F-FDG PET/CT) imaging showed increased carotid arterial wall inflammation, assessed as target-to-background ratio (TBR), in PAD patients without diabetes (PAD-only: n = 11, 1.97 ± 0.57) compared with matched controls (n = 12, 1.49 ± 0.57; p = 0.009), with a significant further TBR increase in PAD patients with type 2 diabetes (PAD-DM, n = 23, 2.90 ± 1, p = 0.033 vs PAD-only). TBR of insulin users (n = 12, 3.31 ± 1.14) was higher compared with patients on oral medication only (n = 11, 2.44 ± 0.76, p = 0.035), despite comparable PAD severity (Fontaine stages), BMI and CRP. Multivariate regression analysis showed that Hba1c and plasma insulin levels, but not dose of exogenous insulin, correlated with TBR.

Conclusions: Concurrent diabetes significantly augments carotid arterial wall inflammation in PAD patients. A further increase in those requiring insulin was observed, which was associated with diabetes severity, rather than with the use of exogenous insulin itself.

Keywords: Diabetes mellitus; Imaging; Inflammation; Insulin; Peripheral vascular disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Quantification of 18F-FDG uptake as the target to background ratio (TBR) in the whole (a, d) carotid arteries, as well as the maximum TBR (b, e) and TBR in the most diseased segment (MDS) (c, f) revealed increased uptake in all segments in PAD subjects compared with healthy controls, and a further increase in PAD subjects with concomitant Diabetes Mellitus (a-c). Within Diabetic subjects, insulin dependent subjects (IDDM) had more severe arterial wall inflammation compared with non-insulin dependent subjects (NIDDM) (d-f). P values are adjusted for age and gender. *p < 0.05, **p < 0.01, ***p < 0.001
Fig. 2
Fig. 2
Target to Background ratio (TBRmean) significantly correlated to fasting glucose levels (Correlation coefficient: 0.845, p < 0.001) (a). Fasting insulin correlated significantly to TBRmean (b) but dose of exogenous insulin did not (Insulin: Correlation coefficient: 0.814, p < 0.001; Exogenous insulin dose: Correlation coefficient: 0.235, p = 0.486). Insulin resistance, measured by HOMA-IR, stongly associated with TBRmean (Correlation coefficient:, 0.876, p < 0.001)

Similar articles

Cited by

References

    1. Stoekenbroek RM, Boekholdt SM, Luben R, Hovingh GK, Zwinderman AH, Wareham NJ, et al. Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study. Eur Heart J. 2016;37:880–9. doi: 10.1093/eurheartj/ehv630. - DOI - PubMed
    1. Steg PG, Bhatt DL, Wilson PWF, D’Agostino R, Ohman EM, Röther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–206. doi: 10.1001/jama.297.11.1197. - DOI - PubMed
    1. Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34:18–22. doi: 10.1016/j.ejvs.2006.10.040. - DOI - PubMed
    1. De Haro J, Acin F, Lopez-Quintana A, Medina FJ, Martinez-Aguilar E, Florez A, et al. Direct association between C-reactive protein serum levels and endothelial dysfunction in patients with claudication. Eur J Vasc Endovasc Surg. 2008;35:480–6. doi: 10.1016/j.ejvs.2007.10.016. - DOI - PubMed
    1. Tarkin JM, Joshi FR, Rudd JHF. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. 2014;11:443–57. doi: 10.1038/nrcardio.2014.80. - DOI - PubMed

Publication types

MeSH terms